Botox
What is it: An injectable neurotoxin regulating nerve signals for possible symptom reliefAKA: Botulinum toxin type A, BTX-A, OnabotulinumtoxinA- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
2 Resources
Referenced in this guide
2 Research papers
Referenced in this guide
2 Expert views
Contributed in this guide
40 Patient views
Contributed in this guide
Figure out what Botox means for you
Page contents
Basics: What you need to know
OnabotulinumtoxinA is a standardized formulation of botulinum toxin type A produced by Allergan, originally known for addressing chronic migraines and muscle spasticity. Recently, it has drawn interest for experimental use in managing lingering symptoms that can appear after a viral infection. While its mechanism involves blocking certain nerve signals, experts continue to analyze its broader impact on inflammation, pain modulation, and other physiological processes.
History and development
- Early medical use: Originally pioneered by Dr. Alan B. Scott in the 1970s to treat crossed eyes (strabismus), botulinum toxin then caught the attention of Allergan, who refined and standardized it for broader applications.
- FDA approval timeline: After initial success, the FDA approved OnabotulinumtoxinA in 1989; since then, it gained approvals for multiple indications such as chronic migraine (2010) and certain forms of muscle stiffness.
- Growing medical applications: Over the years, researchers explored its benefits for conditions like foot spasticity in cerebral palsy and excessive underarm sweating, paving the way for investigating new potential benefits.
What is known
- Nerve-signal interruption: It works by blocking release of acetylcholine, a neurotransmitter responsible for muscle contraction, which helps reduce muscular overactivity and certain pain patterns.
- Potential inflammatory modulation: Some smaller studies suggest it may have indirect effects on inflammatory markers, though more data is needed before drawing firm conclusions.
- Lesser-known benefits: Aside from muscle relaxation, some users report relief from nerve-related pain and tension headaches, potentially improving overall comfort and well-being if properly dosed.
- Possible risk of symptom worsening: In rare cases, injection might trigger increased local discomfort or, in the early stages, mild flu-like symptoms that could momentarily exacerbate existing fatigue.
What is not known
- Long-term impact: Definitive large-scale data concerning its use for persistent post-viral syndromes is still lacking, leaving open questions about the durability of its benefits.
- Exact mechanism in post-viral contexts: While theories focus on nerve pathways and inflammation, there is no consensus regarding how exactly this treatment might help with post-viral complications.
- Optimal dosing and protocols: Current guidelines for migraines and muscle stiffness may not cleanly translate to newer experimental domains; experts caution that more research is needed.
- Blocks nerve signals: Inhibits acetylcholine release to reduce abnormal muscle contractions.
- Dampens pain pathways: May lessen pain by interfering with nerve activity.
- Possible immune influence: Some studies suggest it might modulate local inflammation, though conclusive proof is pending.
- Temporary effect: The impact wears off over months, requiring repeat injections.
- Muscle weakness: Local or regional weakness around the injection site.
- Allergic reactions: Rare but possible, including rashes or breathing difficulties.
- Pain at injection: Swelling, bruising, or tenderness may occur after the procedure.
- Distant spread effects: In very rare cases, the toxin can affect areas away from the site.
- Limited clinical data: Experienced success in other conditions but remains experimental here.
- Variations in response: Some find relief while others report minimal or no benefit.
- Cost and access: Repeated treatments and insurance coverage pose financial and logistical challenges.
- Potential off-label concerns: The lack of formal guidelines raises questions about proper dosing and administration.
Patient views
Experiences
- Patients report significant relief from migraines and head pain.
- Some find it less painful than other treatments like nerve blocks.
- It has helped balance the nervous system and reduce dysautonomia episodes.
- Covered by insurance in some cases, making it more accessible.
Challenges
- Some patients experienced no improvement in symptoms.
- High cost makes it financially unsustainable for many.
- Effects can be temporary, lasting only a few weeks.
- Concerns about injecting Botox into the body due to immune system worries.
Tips
- Consult a trusted doctor experienced with Long Covid treatments.
- Be prepared for temporary effects and plan accordingly.
- Consider combining with other supportive therapies for better results.
- Check insurance coverage to manage costs.
To calculate the reported effectiveness for a patient view, the model first analyses whether it can be ascertained that the person writing the review has had direct experience of the treatment for themselves or a loved one. If so, it then uses sentiment analysis to rate their view from 1-5 on how effective this treatment was for them, with 1 being the least effective, and 5 the most effective.
Patient view
I'm actually getting Botox for cervical dystonia!
Happy to report that I have no side effects and it does elevate my neck pain, which in turn helps a little bit with the overall fatigue. It wears off way too fast though.
October 2024 • /r/cfs
Patient view
Okay, this is a superficial question 😂 has anyone gotten Botox for cosmetic or jaw pain and if so did you have side affects? I am thinking of trying but scared I’ll get a flare or side affects from it.
October 2024 • /r/cfs
Expert views
What they liked
- No expert views provided.
What they didn't like
- No expert views provided.
What are they unsure about
- No expert views provided.
2 expert views
Expert view
Dr. Katy Munro, a GP headache specialist, explains that Botox, originally used for cosmetic purposes, was found to reduce migraine frequency in patients. This led to the development of the 'preempt protocol,' which involves 31 injections in specific areas like the forehead, temples, back of the head, and shoulders. The treatment aims to dull sensory input to the brain, which can trigger migraines. While Botox can cause a frozen forehead, its effects build up over time, and some patients experience significant improvement, allowing them to stop treatment after a year or more.
October 2021 • Episode 15: Dr Katy Munro - Migraine/Headache Specialist
Expert view
Dr. Briar Sexton discusses the use of Botox as a treatment for migraines, emphasizing its potential to significantly improve quality of life for some patients. She shares an example of a patient whose debilitating headaches reduced from 15 days a month to none after Botox treatment, though she notes this is not a typical outcome. Dr. Sexton also addresses concerns about the cost and potential risks of Botox, advocating for patients to make informed decisions based on their own circumstances and priorities. She highlights the importance of broadening perspectives and considering the impact of treatments on overall life quality.
May 2024 • The Invisible Condition Podcast
What and who it targets
Neuropathic pain patients
Pain due to nerve dysfunction or damage.
Chronic headache sufferers
Persistent headaches unresponsive to other treatments.
Muscle spasm sufferers
Frequent involuntary muscle contractions.
Relevant research
How much evidence on this?
- Very few studies link Botox to Long Covid.
- Research mostly focuses on migraines, not Long Covid.
- No large-scale trials for Botox in Long Covid.
- Limited exploration of Botox for Long Covid symptoms.
Research focusing on
- Botox helps migraines and some chronic pain conditions.
- Side effects are usually mild, like injection site pain.
- Long Covid symptoms vary widely among patients.
- Researchers are exploring symptom-specific treatments.
What needs more research?
- Effectiveness of Botox for Long Covid symptoms.
- Long-term safety of Botox in Long Covid patients.
- Mechanism of action for Botox in Long Covid.
- Which Long Covid symptoms Botox might improve.
- ⬤ Minimal research: Very little scientific study exists, with no or very few peer-reviewed studies. Insufficient data for conclusions.
- ⬤⬤ Limited research: Few studies exist, mostly small trials or case reports. Findings are preliminary and lack strong validation.
- ⬤⬤⬤ Moderately researched: Multiple studies, including mid-sized trials, exist. Some findings are replicated, but more research is needed.
- ⬤⬤⬤⬤ Well-researched: Supported by substantial evidence, including at least one large trial or meta-analysis.
- ⬤⬤⬤⬤⬤ Extensively studied: Numerous large studies and meta-analyses exist. Findings are widely accepted with strong scientific consensus.
Research
This study looked at how effective OnabotulinumtoxinA (Botox) is for treating chronic migraines in patients who also have fibromyalgia, a condition that often overlaps with other central sensitization syndromes like chronic fatigue syndrome. Researchers analyzed data from 31 female patients who received Botox treatments every three months over a year at a specialized headache clinic.
The study found that Botox significantly reduced the number of moderate to severe headache days for most patients. By the third month, 65.4% of patients had at least a 30% reduction in headache days, and by one year, 69.5% had at least a 50% reduction. Some patients even experienced a 75% reduction in headache frequency, though 21% stopped treatment due to lack of response.
For people with chronic migraines and fibromyalgia, this study suggests that Botox could be a promising treatment option, especially for those who have not responded to other preventive treatments. It highlights the potential for Botox to improve quality of life by reducing the frequency and severity of headaches.
This study is fairly reliable as it was published in a reputable journal, 'Frontiers in Neurology,' and involved a year-long observation of patients. However, the small sample size and focus on a specific group (female patients with chronic migraines and fibromyalgia) may limit its generalizability to other populations.
November 2020 • Frontiers in neurology
Research
This editorial explored how the COVID-19 pandemic has affected migraine care, including the use of treatments like Botox. It also examined the relationship between migraines and long COVID, discussing how migraines might be a consequence of long COVID.
The paper found that telemedicine is effective for migraine follow-ups and that most migraine treatments, including Botox, can be safely administered during acute COVID-19 with precautions. It also highlighted that migraines may worsen or emerge as part of long COVID, emphasizing the need for adequate resources for treatment.
For individuals with long COVID experiencing migraines, this paper suggests that treatments like Botox could help manage symptoms. It also underscores the importance of accessible care, including telemedicine, to address the challenges posed by long COVID.
As an editorial, this paper provides expert opinions rather than original research. Published in the reputable Journal of Neurology, it is relevant to the field but should be supplemented with clinical studies for stronger evidence.
May 2021 • Journal of neurology
Accessibility
- ⬤ Extremely Difficult to Access: Rare, experimental, or highly specialized. Requires multiple referrals, long wait times, travel, and strict follow-up.
- ⬤⬤ Difficult to Access: Limited to select centers with moderate barriers. Requires referral, potential travel, and wait times of weeks to months.
- ⬤⬤⬤ Moderately Accessible: Available in larger hospitals or clinics. Requires a basic referral, with moderate wait times and some coordination.
- ⬤⬤⬤⬤ Easy to Access: Widely available in most clinics. Minimal referral, short wait times, and simple preparation or follow-up.
- ⬤⬤⬤⬤⬤ Trivial to Access: Easily found in pharmacies or clinics. No referral needed, minimal wait, and straightforward access.
- ⬤ Up to $100
- ⬤⬤ Up to $500
- ⬤⬤⬤ Up to $2000
- ⬤⬤⬤⬤ Up to $10,000
- ⬤⬤⬤⬤⬤ More than $10,000
Method to access
- Requires consultation with a specialist or referral to a clinic offering Botox for Long Covid.
- Typically administered in specialized centers or hospitals.
- No at-home treatment options available.
Cost
- Botox costs approximately $10–$20 per unit, with typical treatments requiring 30–40 units ($300–$800).
- For spasticity-related treatments, costs can reach $1,244 for a 200-unit vial.
- Costs vary by region and insurance coverage.
Insurance cover
- Insurance may cover Botox for medically necessary conditions like dysphagia or headaches, but coverage for Long Covid symptoms is uncertain.
- Medicare and Medicaid may cover some costs if deemed medically necessary.
- Commercial insurance coverage varies significantly.
Locations
- Cleveland Clinic offers multidisciplinary care for Long Covid, including Botox for specific symptoms.
- UCLA Health provides comprehensive Long Covid treatment.
- Directory of Long Covid Clinics lists specialized centers worldwide.
- Other specialized clinics may offer Botox for Long Covid symptoms; consult local healthcare providers.
Frequently asked questions
Key resources
Explore other treatments
It's a lot of information, isn't it?
Turnto's personal AI Assistant can help you figure out what this all means for you
© 2026 Turnto
